Treatment with CPAF increased the proliferation of the PAF-R-expressing B16-PAF-R cells in a dose- and time-dependent manner compared with the B16-MSCV cells, confirming that PAF-R activation enhances the growth of melanoma cells. Here, PTAFR is linked to melanoma.